NCT05626088View on ClinicalTrials.gov

A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil

Active, not recruitingOBSERVATIONAL
Enrollment

1,006

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

December 27, 2024

Study Completion Date

March 30, 2026

Conditions
Ulcerative ColitisCrohn's Disease
Interventions
OTHER

No Intervention

This is a non-interventional study.

Trial Locations (1)

09080-001

Pesquisare Saúde S/S Ltda, Santo André

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY